| Sep 18 |
Cencora: Credentials To Die For, But Underlying Issues Make Case For 'Hold' Rating
|
| Sep 14 |
Cencora Insiders Sell US$13m Of Stock, Possibly Signalling Caution
|
| Sep 10 |
Here's Why We Think Cencora (NYSE:COR) Might Deserve Your Attention Today
|
| Sep 5 |
Cencora lifts FY24 earning guidance
|
| Aug 31 |
Medical distributors, health plans ink $300M opioid settlement
|
| Aug 30 |
Investing in Cencora (NYSE:COR) five years ago would have delivered you a 195% gain
|
| Aug 15 |
Cencora Elects Frank Clyburn to Its Board of Directors
|
| Aug 14 |
Why Cencora (COR) is a Top Value Stock for the Long-Term
|
| Aug 11 |
Insiders At Cencora Sold US$13m In Stock, Alluding To Potential Weakness
|
| Aug 4 |
Cencora (NYSE:COR) Could Be A Buy For Its Upcoming Dividend
|
